Antisense compounds, compositions and methods are provided for modulating
the expression of C/EBP beta. The compositions comprise antisense
compounds, particularly antisense oligonucleotides, targeted to nucleic
acids encoding C/EBP beta. Methods of using these compounds for
modulation of C/EBP beta expression and for treatment of diseases
associated with expression of C/EBP beta are provided.